Study of Satisfaction of Patients and Care Providers for an Alternate Follow-up With In-hospital Consults and Tele-consult for Patients With Cystic Fibrosis
NCT05249322 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2023-09-28
Summary
The pandemic forced us to develop home follow-up for patients with chronical diseases . In the same time, the new era of treatment for cystic fibrosis considerably improves the health of patients with this pathology.
This study aims to assess the satisfaction of patients and care providers for an alternated follow-up between tele-consults and in-hospital consults during one year for patients with cystic fibrosis treated by Kaftrio® since at least one year and stable.
Conditions
Interventions
- OTHER
-
Follow-up alternating between face-to-face consultation and teleconsultation every three months.
The intervention will be an alternate follow-up every three months with: * A tele-consult: with paramedical consult (with assistance for home-spirometry) and medical consult for about 1h30 in total, make with a HCL platform for telemedicine. * An usual in-hospital consult of about 1h30 with paramedical and medical consult.
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Principal Investigators
-
Thomas VIDAL · adult cystic fibrosis centre Lyon
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-31
- Primary Completion
- 2024-03-31
- Completion
- 2024-03-31
Countries
- France
Study Locations
More Related Trials
-
Anti-IL5 and Other Biotherapies in Cystic Fibrosis
NCT04256772 ·Status: UNKNOWN
-
Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis
NCT00850551 ·Status: COMPLETED ·Phase: NA
-
Concerns of Children Whose Parents Have Cystic Fibrosis
NCT04702386 ·Status: COMPLETED
-
Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic Fibrosis
NCT03357913 ·Status: COMPLETED
-
MUCOviscidose EXacerbation Outils Connectés Education Thérapeutique
NCT03304028 ·Status: TERMINATED ·Phase: NA
-
Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination
NCT01499914 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
NCT02109822 ·Status: COMPLETED
-
COVID-19 Antibody Responses in Cystic Fibrosis
NCT05614336 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Lung Clearance Index
NCT02342951 ·Status: COMPLETED ·Phase: NA
-
Tele-Coaching Intervention to Improve Treatment Adherence in Cystic Fibrosis
NCT03921229 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of CFTR Modulators According to Co-therapy
NCT05663255 ·Status: UNKNOWN
-
A Usability Validation of the MuCopilot Mobile Application, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis
NCT06132048 ·Status: RECRUITING ·Phase: NA
-
Analysis T Cells Response for Identification of Aspergillus Bronchitis With Cystic Fibrosis Patients
NCT02550041 ·Status: TERMINATED ·Phase: NA
-
Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients
NCT03736096 ·Status: COMPLETED
-
Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic Fibrosis
NCT00531531 ·Status: COMPLETED
-
Combating Diagnostic Wandering and Impasse for Cystic Fibrosis
NCT05654480 ·Status: UNKNOWN
-
Patient Outcomes of Clinic Transition From Face to Face Encounter to Telemedicine in Cystic Fibrosis
NCT04402801 ·Status: COMPLETED
-
Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis
NCT04024423 ·Status: COMPLETED
-
Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients.
NCT01848392 ·Status: COMPLETED
-
Oral Health Status of Cystic Fibrosis Patients. An Online Survey in Collaboration With the Vaincre la Mucoviscidose Patient Association.
NCT06356246 ·Status: RECRUITING
-
Validation of Therapeutic Efficacy Targeting the Splicing Variants in Cystic Fibrosis and CFTR Pathologies
NCT05100823 ·Status: TERMINATED ·Phase: NA
-
Performances and Safety of MuCopilot, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis
NCT06147778 ·Status: COMPLETED ·Phase: NA
-
Early Intervention in Cystic Fibrosis Exacerbation
NCT01104402 ·Status: COMPLETED ·Phase: NA
-
Determinants of Daily Physical Activity Level in Patients With Cystic Fibrosis - Pilot Study Protocol
NCT05206097 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis
NCT06602869 ·Status: RECRUITING